Information about BioGenCell Europe SA
My details
*
*
*

BioGenCell Europe SA (SA)

Company information

Status
Active

Enterprise number

BE0678.674.356

VAT liability
Yes
Established
18-07-2017
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from BioGenCell Europe SA

2024 2023 2022 2021
Profit/Loss -6,021 31 % -8,676 -6 % -8,206 19 % -10,176
Equity 69,966 -8 % 75,988 -10 % 84,664 -9 % 92,870
Gross margin -5,427 33 % -8,112 -7 % -7,587 21 % -9,615

Publications from BioGenCell Europe SA

Date Publication
08-02-2018 Registered Office - Resignations, Appointments (FR)
01-08-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of BioGenCell Europe SA?
The VAT number of BioGenCell Europe SA is BE 0678.674.356.
Wat is the PEPPOL ID of BioGenCell Europe SA?
The PEPPOL ID of BioGenCell Europe SA is 0208:0678674356. Log in or start a free trial to see the full overview.
When was BioGenCell Europe SA founded?
BioGenCell Europe SA was founded on 18-07-2017.
What is the address of BioGenCell Europe SA?
The current registered office of BioGenCell Europe SA is located at Avenue Louis David 68, 1410 Waterloo.
When was the last time BioGenCell Europe SA filed their annual financial statements?
The most recent financial statements of BioGenCell Europe SA were filed on 01-04-2025.
How many employees does BioGenCell Europe SA have?
There are currently no employees working at BioGenCell Europe SA or no workforce information is available.
What is the annual turnover of BioGenCell Europe SA?
At the time of its most recent financial statements, BioGenCell Europe SA did not publish any turnover figures. BioGenCell Europe SA reported a gross margin of -€5,427.44.